Literature DB >> 8669470

Expression of neurofilaments and of a titin epitope in thymic epithelial tumors. Implications for the pathogenesis of myasthenia gravis.

A Marx1, A Wilisch, A Schultz, A Greiner, B Magi, V Pallini, B Schalke, K Toyka, W Nix, T Kirchner, H K Müller-Hermelink.   

Abstract

Autoantibodies against both striated muscle proteins, particularly titin, and the acetylcholine receptor are a hallmark of thymoma-associated myasthenia gravis. However, the stimulus for these responses remains enigmatic as whole titin is not detectable in these tumors. This study reports that in thymomas with cortical differentiation many of the neoplastic epithelial cells expressed low and medium molecular weight neurofilaments detected with several antibodies (on selections and blots) and at the RNA level (by reverse transcriptase polymerase chain reaction). Moreover, higher molecular weight forms sharing at least one epitope with titin were detectable slightly less frequently, as were the more strongly phosphorylated epitopes. In stark contrast, in medullary and mixed thymomas, and especially in the normal thymus, immunoreactivity with anti-neurofilament antibodies was rare. This aberrant overexpression of a titin epitope by epithelial cells with antigen-presenting phenotype in an inappropriate cortical microenvironment suggests that they might autosensitize maturing T cells there and so initiate anti-titin autoimmunity in these patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8669470      PMCID: PMC1861646     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  47 in total

1.  Changes in serum complement activity in patients with myasthenia gravis.

Authors:  W L NASTUK; O J PLESCIA; K E OSSERMAN
Journal:  Proc Soc Exp Biol Med       Date:  1960-10

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 3.  Pathology of thymic epithelial tumors.

Authors:  H K Müller-Hermelink; M Marino; G Palestro
Journal:  Curr Top Pathol       Date:  1986

4.  Reactivity of a panel of neurofilament antibodies on phosphorylated and dephosphorylated neurofilaments.

Authors:  G Shaw; M Osborn; K Weber
Journal:  Eur J Cell Biol       Date:  1986-10       Impact factor: 4.492

5.  Monoclonal antibodies show that neurofibrillary tangles and neurofilaments share antigenic determinants.

Authors:  B H Anderton; D Breinburg; M J Downes; P J Green; B E Tomlinson; J Ulrich; J N Wood; J Kahn
Journal:  Nature       Date:  1982-07-01       Impact factor: 49.962

6.  Multiple phosphorylation sites in mammalian neurofilament polypeptides.

Authors:  J P Julien; W E Mushynski
Journal:  J Biol Chem       Date:  1982-09-10       Impact factor: 5.157

7.  The structure of a human neurofilament gene (NF-L): a unique exon-intron organization in the intermediate filament gene family.

Authors:  J P Julien; F Grosveld; K Yazdanbaksh; D Flavell; D Meijer; W Mushynski
Journal:  Biochim Biophys Acta       Date:  1987-06-06

8.  Follow-up study of thymomas with special reference to their clinical stages.

Authors:  A Masaoka; Y Monden; K Nakahara; T Tanioka
Journal:  Cancer       Date:  1981-12-01       Impact factor: 6.860

9.  Thymomatous epithelial cells and skeletal muscle share a common epitope defined by a monoclonal antibody.

Authors:  M Dardenne; W Savino; J F Bach
Journal:  Am J Pathol       Date:  1987-01       Impact factor: 4.307

10.  The human mid-size neurofilament subunit: a repeated protein sequence and the relationship of its gene to the intermediate filament gene family.

Authors:  M W Myers; R A Lazzarini; V M Lee; W W Schlaepfer; D L Nelson
Journal:  EMBO J       Date:  1987-06       Impact factor: 11.598

View more
  11 in total

1.  Antibodies against low-density lipoprotein receptor-related protein 4 induce myasthenia gravis.

Authors:  Chengyong Shen; Yisheng Lu; Bin Zhang; Dwight Figueiredo; Jonathan Bean; Jiung Jung; Haitao Wu; Arnab Barik; Dong-Min Yin; Wen-Cheng Xiong; Lin Mei
Journal:  J Clin Invest       Date:  2013-11-08       Impact factor: 14.808

2.  Epitopes expressed in myasthenia gravis (MG) thymomas are not recognized by patients' T cells or autoantibodies.

Authors:  N Nagvekar; L W Jacobson; N Willcox; A Vincent
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

3.  A pathogenetic role for the thymoma in myasthenia gravis. Autosensitization of IL-4- producing T cell clones recognizing extracellular acetylcholine receptor epitopes presented by minority class II isotypes.

Authors:  N Nagvekar; A M Moody; P Moss; I Roxanis; J Curnow; D Beeson; N Pantic; J Newsom-Davis; A Vincent; N Willcox
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

4.  CD24 on thymic APCs regulates negative selection of myelin antigen-specific T lymphocytes.

Authors:  Xuejun Zhang; Jin-Qing Liu; Yun Shi; Hugh H Reid; Richard L Boyd; Mazin Khattabi; Hani Y El-Omrani; Pan Zheng; Yang Liu; Xue-Feng Bai
Journal:  Eur J Immunol       Date:  2012-01-19       Impact factor: 5.532

5.  The Integrated Genomic Landscape of Thymic Epithelial Tumors.

Authors:  Milan Radovich; Curtis R Pickering; Ina Felau; Gavin Ha; Hailei Zhang; Heejoon Jo; Katherine A Hoadley; Pavana Anur; Jiexin Zhang; Mike McLellan; Reanne Bowlby; Thomas Matthew; Ludmila Danilova; Apurva M Hegde; Jaegil Kim; Mark D M Leiserson; Geetika Sethi; Charles Lu; Michael Ryan; Xiaoping Su; Andrew D Cherniack; Gordon Robertson; Rehan Akbani; Paul Spellman; John N Weinstein; D Neil Hayes; Ben Raphael; Tara Lichtenberg; Kristen Leraas; Jean Claude Zenklusen; Junya Fujimoto; Cristovam Scapulatempo-Neto; Andre L Moreira; David Hwang; James Huang; Mirella Marino; Robert Korst; Giuseppe Giaccone; Yesim Gokmen-Polar; Sunil Badve; Arun Rajan; Philipp Ströbel; Nicolas Girard; Ming S Tsao; Alexander Marx; Anne S Tsao; Patrick J Loehrer
Journal:  Cancer Cell       Date:  2018-02-12       Impact factor: 31.743

6.  Thymus neuroendocrine tumors with CTNNB1 gene mutations, disarrayed ß-catenin expression, and dual intra-tumor Ki-67 labeling index compartmentalization challenge the concept of secondary high-grade neuroendocrine tumor: a paradigm shift.

Authors:  Alessandra Fabbri; Mara Cossa; Angelica Sonzogni; Paolo Bidoli; Stefania Canova; Diego Cortinovis; Maria Ida Abbate; Fiorella Calabrese; Nazarena Nannini; Francesca Lunardi; Giulio Rossi; Stefano La Rosa; Carlo Capella; Elena Tamborini; Federica Perrone; Adele Busico; Iolanda Capone; Barbara Valeri; Ugo Pastorino; Adriana Albini; Giuseppe Pelosi
Journal:  Virchows Arch       Date:  2017-04-27       Impact factor: 4.064

7.  The significance of titin antibodies in myasthenia gravis--correlation with thymoma and severity of myasthenia gravis.

Authors:  Xiang-Jun Chen; Jian Qiao; Bao-Guo Xiao; Chuan-Zhen Lu
Journal:  J Neurol       Date:  2004-08       Impact factor: 4.849

8.  Three types of striational antibodies in myasthenia gravis.

Authors:  Shigeaki Suzuki; Kimiaki Utsugisawa; Yuriko Nagane; Norihiro Suzuki
Journal:  Autoimmune Dis       Date:  2011-07-17

9.  Human autoantibodies reveal titin as a chromosomal protein.

Authors:  C Machado; C E Sunkel; D J Andrew
Journal:  J Cell Biol       Date:  1998-04-20       Impact factor: 10.539

Review 10.  Narrative review of immunotherapy in thymic malignancies.

Authors:  Jose Carlos Benitez; Benjamin Besse
Journal:  Transl Lung Cancer Res       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.